Evidence map›Paper›PMID 23430615›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2013

Endothelial outgrowth cells shift macrophage phenotype and improve kidney viability in swine renal artery stenosis.

Alfonso Eirin, Xiang-Yang Zhu, Zilun Li, Behzad Ebrahimi, Xin Zhang, Hui Tang, Michael J Korsmo, Alejandro R Chade, Joseph P Grande, Christopher J Ward and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Endothelial Progenitor Cells: Disease Markers and Potential Therapy in Kidney Disease.Journal of the American Society of Nephrology : JASN · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Novel therapeutic strategies for renovascular disease.Current opinion in nephrology and hypertension · 2019
    Review
  16. Emerging Paradigms in Chronic Kidney Ischemia.Hypertension (Dallas, Tex. : 1979) · 2018
    Review
  17. Article
  18. A translational model of chronic kidney disease in swine.American journal of physiology. Renal physiology · 2018
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Alfonso EirinDivision of Nephrology and Hypertension, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.
Xiang-Yang Zhu
Zilun Li
Behzad Ebrahimi
Xin Zhang
Hui Tang
Michael J Korsmo
Alejandro R Chade
Joseph P Grande
Christopher J Ward
Robert D Simari
Amir Lerman
Stephen C Textor
Lilach O Lerman
Sun Yat-sen University · CNThe First Affiliated Hospital, Sun Yat-sen University · CN

Funding

Tissue Oxygenation in Human Renovascular HypertensionP01HL085307 · NHLBI · MAYO CLINIC ROCHESTER · PI TEXTOR, STEPHEN C · 2007 to 2011
$10.4M
Microcirculation in Renovascular HypertensionR01HL095638 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI CHADE, ALEJANDRO ROBERTO · 2010 to 2021
$3.9M
CT imaging for the assessment of kidney injury distal to renal artery stenosisR01DK073608 · NIDDK · MAYO CLINIC ROCHESTER · PI LERMAN, LILACH O · 2006 to 2015
$3.1M
CT Evaluation of the Myocardial Effects of Risk FactorsR01HL077131 · NHLBI · MAYO CLINIC ROCHESTER · PI LERMAN, LILACH O · 2004 to 2013
$2.8M
EXTRAMURAL RES FACIL IMPROVEMENT PROG: POLYCYSTIC KIDNEY DISEASE, RENAL STUDIES,C06RR018898 · NCRR · MAYO CLINIC · PI BURNETT, JOHN C · 2004 to 2004
$2.3M
Autologous Progenitor Cells Delivery in Renovascular DiseaseR21DK077013 · NIDDK · MAYO CLINIC ROCHESTER · PI LERMAN, LILACH O · 2008 to 2009
$416k
NCRR NIH HHS C06 RR018898NCRR NIH HHS C06-RR018898NHLBI NIH HHS HL085307NHLBI NIH HHS HL095638NHLBI NIH HHS HL77131NHLBI NIH HHS P01 HL085307NHLBI NIH HHS R01 HL077131NHLBI NIH HHS R01 HL095638NIDDK NIH HHS DK73608NIDDK NIH HHS DK77013NIDDK NIH HHS R01 DK073608NIDDK NIH HHS R21 DK077013
6 · The paper itself

Abstract

objectiveEndothelial outgrowth cells (EOC) decrease inflammation and improve endothelial repair. Inflammation aggravates kidney injury in renal artery stenosis (RAS), and may account for its persistence upon revascularization. We hypothesized that EOC would decrease inflammatory (M1) macrophages and improve renal recovery in RAS. APPROACH AND

resultsPigs with 10 weeks of RAS were studied 4 weeks after percutaneous transluminal renal angioplasty (PTRA+stenting) or sham, with or without adjunct intrarenal delivery of autologous EOC (10×10(6)), and compared with similarly treated normal controls (n=7 each). Single-kidney function, microvascular and tissue remodeling, inflammation, oxidative stress, and fibrosis were evaluated. Four weeks after PTRA, EOC were engrafted in injected RAS-kidneys. Stenotic-kidney glomerular filtration rate was restored in RAS+EOC, RAS+PTRA, and RAS+PTRA+EOC pigs, whereas stenotic-kidney blood flow and angiogenesis were improved and fibrosis attenuated only in EOC-treated pigs. Furthermore, EOC increased cell proliferation and decreased the ratio of M1 (inflammatory)/M2 (reparative) macrophages, as well as circulating levels and stenotic-kidney release of inflammatory cytokines. Cultured-EOC released microvesicles in vitro and induced phenotypic switch (M1-to-M2) in cultured monocytes, which was inhibited by vascular endothelial growth factor blockade. Finally, a single intrarenal injection of rh-vascular endothelial growth factor (0.05 μg/kg) in 7 additional RAS pigs also restored M1/M2 ratio 4 weeks later.

conclusionsIntrarenal infusion of EOC after PTRA induced a vascular endothelial growth factor-mediated attenuation in macrophages inflammatory phenotype, preserved microvascular architecture and function, and decreased inflammation and fibrosis in the stenotic kidney, suggesting a novel mechanism and therapeutic potential for adjunctive EOC delivery in experimental RAS to improve PTRA outcomes.

Indexed as

AnimalsCell ProliferationEndothelial CellsFibrosisHemodynamicsInflammationKidneyMacrophage ActivationMacrophagesPhenotypeRenal Artery ObstructionSwineVascular Endothelial Growth Factor AVascular Endothelial Growth Factor A

Identifiers

PMID23430615
PMCPMC3644980
OpenAlexW2134064731

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.